EVERSANA is leading conversations about next-generation commercialization as the presenting sponsor at the global health innovation event Frontiers Health 2024.
As we expand our global reach in Europe and beyond, Frontiers Health represents the perfect event for EVERSANA to be a part of as the presenting sponsor. During the two-day conference, ecosystem leaders, founders, C-suite executives, and senior government and academic thought leaders will gather to discuss the next frontier of innovation in health and life sciences. This perfectly aligns with our mission, and we look forward to meeting like-minded health innovators who share our purpose of making a healthier world for all.
Here in Europe, we are seeing a growing interest in our services, especially medical information, market access, value & evidence and deployment solutions, as well as marketing agency services. AI and how it is revolutionizing industries, direct-to-patient models and other emerging trends present endless opportunities for life sciences companies to bring new solutions to market with our support.
However, commercializing innovative healthcare solutions is a challenging endeavor. It requires experts who understand the complexities of the market and have a proven track record. Additionally, it necessitates the support of a larger ecosystem that can elevate groundbreaking work through strategic partnerships. This is where Frontiers Health plays a crucial role.
At Frontiers Health, leaders from across the industry come together to share insights, forge partnerships and accelerate innovation. This year promises to be no different, offering invaluable opportunities for collaboration and advancement.
I am honored to be moderating a panel titled “Next-Gen Global Commercialization,” where innovators in oncology and rare and infectious diseases will share their journeys to global commercialization and launch excellence. We will discuss how leveraging innovative, integrated and streamlined models can maximize brand value and improve patient access and outcomes. This session aims to provide practical insights and strategies for navigating the unpredictable market landscape, which is essential for effective commercialization infrastructures and rapid product launches.
EVERSANA has historically played an integral role in the conference, and we had a number of speakers on stage last year, including:
- Pierantonio Russo, MD, Chief Medical Officer
- Abid Rahman, Senior Vice President, Innovation
- Martin Culjat, PhD, Senior Vice President, Global Head of Digital Medicine & Regulatory Innovation
- James May, Global Media Lead
This year promises to be our best yet, and we hope you’ll join us! We’ve got an amazing lineup of speakers, including Roberto Ascione, President, Health Innovation, and Jim Lang, CEO. It’s an event you will not want to miss.
Join us for this transformative discussion on 17-18 October in Berlin, Germany! Buy your tickets today and use the code FHEVS20 to save 20% at www.frontiers.health.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…